Histologic changes of porcine portal vein anastomosis after electrochemotherapy with bleomycin

Bioelectrochemistry. 2023 Dec:154:108509. doi: 10.1016/j.bioelechem.2023.108509. Epub 2023 Jul 13.

Abstract

Electrochemotherapy (ECT1) is used for treatment of unresectable abdominal malignancies. This study aims to show that ECT of porcine portal vein anastomosis is safe and feasible in order to extend the indications for margin attenuation after resection of locally advanced pancreatic carcinoma. No marked differences were found between the control group and ECT treated groups. Electroporation thus caused irreversible damage to the vascular smooth muscle cells in tunica media that could bedue to the narrow irreversible electroporation zone that may occur near the electrodes, or due to vasa vasorum thrombosis in the tunica externa. Based on the absence of vascular complications, and similar histological changes in lienal veinanastomosis, we can conclude that ECT of portal vein anastomosis is safe and feasible.

Keywords: Electrochemotherapy; Pancreatic cancer; Portal vein anastomosis.

MeSH terms

  • Anastomosis, Surgical
  • Animals
  • Bleomycin
  • Electrochemotherapy*
  • Pancreatic Neoplasms* / drug therapy
  • Portal Vein / surgery
  • Swine

Substances

  • Bleomycin